Hormone replacement therapy: Is it right for you?

March 12, 2000

Find out at Mayo Clinic Health Oasis, www.mayohealth.org

ROCHESTER, MINN. -- Menopause will affect every woman's life. Usually occurring between the ages of 45 and 55, menopause is when menstruation stops completely, and often causes numerous problems as a woman's body responds to shifting hormone levels. This week, Mayo Clinic Health Oasis, www.mayohealth.org, examines the long-term benefits as well as the risks of using hormone replacement therapy (HRT) to ease these symptoms and reduce the risk of osteoporosis and possibly heart disease. HRT is taken by about 10 percent of U.S. women, most of whom are at menopause and beyond. Many women, however, worry about whether they should take HRT. Fears about the risk of getting breast cancer prevent some from ever taking it.

Studies reported recently in the Journal of the American Medical Association and the Journal of the National Cancer Institute concluded that use of HRT may increase a woman's risk of breast cancer. The Mayo Clinic Health Oasis article puts that increased risk in context and explains how the use of HRT compares with other breast cancer risk factors.

This week's article on Mayo Clinic Health Oasis about HRT and breast cancer:
* explains the relative risk of HRT and breast cancer.
* assesses the benefits and the risks of HRT.
* compares decision factors to use HRT.
* offers suggestions to manage a healthy lifestyle during menopause.
Visuals are available at www.mayo.edu/news

For this helpful article, click on the Women's Center/Menopause section when you visit Mayo Clinic Health Oasis at www.mayohealth.org.

Mayo Clinic

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.